Document is current
Any future updates will be listed below
-
Authors
Peng, Hui
Chhimwal, Jyoti https://orcid.org/0000-0002-6155-7721
Fan, Wei
Wang, Jiaohong
Barbier-Torres, Lucía
Sinha, Sonal
Chatterjee, Avradip https://orcid.org/0000-0001-8345-4339
Zhang, Yi
Tomasi, Maria Lauda https://orcid.org/0000-0001-8156-9052
Mato, José M. https://orcid.org/0000-0003-1264-3153
Murali, Ramachandran
Lu, Shelly C. https://orcid.org/0000-0003-2128-5407
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01CA233452)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (P01CA233452)
- License Information
-
More Information
Article History
Received: 15 October 2024
Revised: 15 January 2026
Accepted: 10 February 2026
First Online: 20 February 2026
Competing interests
: SCL and RM have filed a patent for small molecule inhibitors of GIT1 (Title: COMPOUNDS AND METHODS FOR TREATING CANCERS; Application No.: 63/422,672; Filed: November 4, 2022). The other authors declare that they have no competing interests.
: We confirm that all experiments were performed in accordance with relevant guidelines and regulations and approved by the Institutional Animal Care and Use Committee of Cedars-Sinai Medical Center.
